.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 9,102,618

« Back to Dashboard

Details for Patent: 9,102,618

Title:Prodrugs of NH-acidic compounds
Abstract: The invention provides a method of sustained delivery of a lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug by administering to a patient an effective amount of a prodrug compound of the invention wherein upon administration to the patient, release of the parent drug from the prodrug is sustained release. Prodrug compounds suitable for use in the methods of the invention are labile conjugates of parent drugs that are derivatized through carbonyl linked prodrug moieties. The prodrug compounds of the invention can be used to treat any condition for which the lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug is useful as a treatment.
Inventor(s): Blumberg; Laura Cook (Lincoln, MA), Remenar; Julius F. (Framingham, MA), Almarsson; Orn (Shrewsbury, MA), Zeidan; Tarek A. (Watertown, MA)
Assignee: Alkermes Pharma Ireland Limited (Dublin, IE)
Filing Date:Feb 04, 2014
Application Number:14/172,391
Claims:1. A compound of having the formula: ##STR01647## wherein represents a single or double bond; R.sub.1 is selected from --C(R.sub.A)(R.sub.B)--OC(O)OR.sub.20, --C(R.sub.A)(R.sub.B)--OC(O)R.sub.20, --C(R.sub.A)(R.sub.B)--OC(O)NR.sub.20R.sub.21; Each R.sub.A and R.sub.B independently selected from hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl; Each R.sub.20 and R.sub.21 is independently selected from hydrogen, aliphatic, substituted aliphatic, aryl or substituted aryl; Each R.sub.3, R.sub.4 and R.sub.5 is independently selected from absent, hydrogen, halogen, --OR.sub.10, --SR.sub.10, --NR.sub.10R.sub.11, --C(O)R.sub.10, optionally substituted aliphatic, optionally substituted aryl or optionally substituted heterocyclyl; each R.sub.10 and R.sub.11 is independently absent, hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl; alternatively two R.sub.10 and R.sub.11 together with the atoms to which they are attached and any intervening atoms may form an additional optionally substituted, 3, 4, 5, 6 or 7 membered ring; A is selected from absent, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, --S--, --O--, --S(O)--, --S(O).sub.2--, --S[C(R.sub.30)(R.sub.31)].sub.u--, --S(O)[C(R.sub.30)(R.sub.31)].sub.u--, --S(O).sub.2[C(R.sub.30)(R.sub.31)].sub.u--, --O[C(R.sub.30)(R.sub.31)].sub.u--, --N(R.sub.30)--, --N(R.sub.30)[C(R.sub.31)(R.sub.32)].sub.u--, or --[C(R.sub.30)(R.sub.31)].sub.u, or --C(O)[C(R.sub.30)(R.sub.31)].sub.u--; Each u is independently 1, 2, 3, 4, 5, 6 or 7; D is selected from absent, --O--, --NR.sub.33, --C(R.sub.34)(R.sub.35)--, --S--, --S(O)--,--S(O).sub.2--, or --C(O)--; Each R.sub.30, R.sub.31, R.sub.32, R.sub.33, R.sub.34, and R.sub.35 is independently selected from absent, hydrogen, halogen, --OR.sub.10, --SR.sub.10, --NR.sub.10R.sub.11--, --C(O)R.sub.10, optionally substituted aliphatic, optionally substituted aryl or optionally substituted heterocyclyl; R.sub.2 is selected from absent, hydrogen, halogen, --OR.sub.10, --SR.sub.10, --NR.sub.10R.sub.11--, optionally substituted aliphatic, optionally substituted aryl or optionally substituted heterocyclyl; r is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11; each G.sub.3 and G.sub.4 is independently selected from --N--, --C(R.sub.10)--[C(R.sub.10)(R.sub.11)].sub.a--, wherein a is 0, 1 or 2; m and q are independently selected from 0, 1, and 2; X.sub.20 is --C(R.sub.10)-- or --N--; and, p is selected 0, 1, 2 or 3.

2. A compound of claim 1 having the formula: ##STR01648## wherein represents a single or double bond; R.sub.1 is selected from --C(R.sub.A)(R.sub.B)--OC(O)OR.sub.20, --C(R.sub.A)(R.sub.B)--OC(O)R.sub.20, --C(R.sub.A)(R.sub.B)--OC(O)NR.sub.20R.sub.21; Each R.sub.A and R.sub.B is independently selected from hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl; Each R.sub.20 and R.sub.21 is independently selected from hydrogen, aliphatic, substituted aliphatic, aryl or substituted aryl; Each R.sub.3, R.sub.4 and R.sub.5 is independently selected from absent, hydrogen, halogen, --OR.sub.10, --SR.sub.10, --NR.sub.10R.sub.11, --C(O)R.sub.10, optionally substituted aliphatic, optionally substituted aryl or optionally substituted heterocyclyl; Each R.sub.10 and R.sub.11 is independently absent, hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl; alternatively two R.sub.10 and R.sub.11 together with the atoms to which they are attached and any intervening atoms may form an additional optionally substituted, 3, 4, 5, 6 or 7 membered ring; A is selected from absent, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkenyl, --S--, --O--, --S(O)--, --S(O).sub.2--, --S[C(R.sub.30)(R.sub.31)].sub.u--, --S(O)[C(R.sub.30)(R.sub.31)].sub.u--, --S(O).sub.2[C(R.sub.30)(R.sub.31)].sub.u--, --O[C(R.sub.30)(R.sub.31)].sub.u--, --N(R.sub.30)--, --N(R.sub.30)[C(R.sub.31)(R.sub.32)].sub.u--, or --[C(R.sub.30)(R.sub.31)].sub.u, or --C(O)[C(R.sub.30)(R.sub.31)].sub.u--, Each u is independently 1, 2, 3, 4, 5, 6 or 7; D is selected from absent, --O--, --NR.sub.33, --C(R.sub.34)(R.sub.35)--, --S--, --S(O)--, --S(O).sub.2--, or --C(O)--; Each R.sub.30, R.sub.31, R.sub.32 R.sub.33, R.sub.34, and R.sub.35 is independently selected from absent, hydrogen, halogen, --OR.sub.10, --SR.sub.10, --NR.sub.10R.sub.11--, --C(O)R.sub.10, optionally substituted aliphatic, optionally substituted aryl or optionally substituted heterocyclyl; and, R.sub.2, p, r, m and q are as defined in claim 1.

3. A compound of Formula XIIC: ##STR01649## wherein represents a single or double bond; R.sub.1 is selected from --C(R.sub.A)(R.sub.B)--OC(O)OR.sub.20, --C(R.sub.A)(R.sub.B)--OC(O)R.sub.20, or --C(R.sub.A)(R.sub.B)--OC(O)NR.sub.20R.sub.21; wherein each R.sub.A and R.sub.B is independently selected from hydrogen, halogen, aliphatic, substituted aliphatic, aryl or substituted aryl; each R.sub.20 and R.sub.21 is independently selected from hydrogen, aliphatic, substituted aliphatic, aryl or substituted aryl; and, w is 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11.

4. A compound of Table H or a pharmaceutically acceptable salt thereof: TABLE-US-00027 TABLE H No Structure 1100. ##STR01650## 1101. ##STR01651## 1102. ##STR01652## 1103. ##STR01653## 1104. ##STR01654## 1105. ##STR01655## 1106. ##STR01656## 1107. ##STR01657## 1108. ##STR01658## 1109. ##STR01659## 1110. ##STR01660## 1111. ##STR01661## 1112. ##STR01662## 1113. ##STR01663## 1114. ##STR01664## 1115. ##STR01665## 1116. ##STR01666## 1117. ##STR01667## 1118. ##STR01668## 1119. ##STR01669## 1120. ##STR01670## 1121. ##STR01671## 1122. ##STR01672## 1123. ##STR01673## 1124. ##STR01674## 1125. ##STR01675## 1126. ##STR01676## 1127. ##STR01677## 1128. ##STR01678## 1129. ##STR01679## 1130. ##STR01680## 1131. ##STR01681## 1132. ##STR01682## 1133. ##STR01683## 1134. ##STR01684## 1135. ##STR01685## 1136. ##STR01686## 1137. ##STR01687## 1138. ##STR01688## 1139. ##STR01689## 1140. ##STR01690## 1141. ##STR01691## 1142. ##STR01692## 1143. ##STR01693## 1144. ##STR01694## 1145. ##STR01695## 1146. ##STR01696## 1147. ##STR01697## 1148. ##STR01698## 1149. ##STR01699## 1150. ##STR01700## 1151. ##STR01701## 1152. ##STR01702## 1153. ##STR01703## 1154. ##STR01704## 1155. ##STR01705## 1156. ##STR01706## 1157. ##STR01707## 1158. ##STR01708## 1159. ##STR01709## 1160. ##STR01710## 1161. ##STR01711## 1162. ##STR01712## 1163. ##STR01713## 1164. ##STR01714## 1165. ##STR01715## 1166. ##STR01716## 1167. ##STR01717##

5. A compound of Table I or a pharmaceutically acceptable salt thereof: TABLE-US-00028 No Structure 1200. ##STR01718## 1201. ##STR01719## 1202. ##STR01720## 1203. ##STR01721## 1204. ##STR01722## 1205. ##STR01723## 1206. ##STR01724## 1207. ##STR01725## 1208. ##STR01726## 1209. ##STR01727## 1210. ##STR01728## 1211. ##STR01729## 1212. ##STR01730## 1213. ##STR01731## 1214. ##STR01732## 1215. ##STR01733## 1216. ##STR01734## 1217. ##STR01735## 1218. ##STR01736## 1219. ##STR01737## 1220. ##STR01738## 1221. ##STR01739## 1222. ##STR01740## 1223. ##STR01741## 1224. ##STR01742## 1225. ##STR01743## 1226. ##STR01744## 1227. ##STR01745## 1228. ##STR01746## 1229. ##STR01747## 1230. ##STR01748## 1231. ##STR01749## 1232. ##STR01750## 1233. ##STR01751## 1234. ##STR01752## 1235. ##STR01753## 1236. ##STR01754## 1237. ##STR01755## 1238. ##STR01756## 1239. ##STR01757## 1240. ##STR01758## 1241. ##STR01759## 1242. ##STR01760## 1243. ##STR01761## 1244. ##STR01762## 1245. ##STR01763## 1246. ##STR01764## 1247. ##STR01765## 1248. ##STR01766## 1249. ##STR01767## 1250. ##STR01768## 1251. ##STR01769## 1252. ##STR01770## 1253. ##STR01771## 1254. ##STR01772## 1255. ##STR01773## 1256. ##STR01774## 1257. ##STR01775## 1258. ##STR01776## 1259. ##STR01777## 1260. ##STR01778## 1261. ##STR01779## 1262. ##STR01780## 1263. ##STR01781## 1264. ##STR01782## 1265. ##STR01783## 1266. ##STR01784## 1267. ##STR01785## .
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc